Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Advantis Platform

K-Number: K222975 · 2023-03-01

ApplicantAdvantis Medical Imaging Single Member P.C.
Decision Date2023-03-01
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Advantis Platform is a medical device manufactured by Advantis Medical Imaging Single Member P.C.. It received FDA 510(k) clearance on 2023-03-01 under approval number K222975. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Advantis Platform?

Advantis Platform is a medical device that received FDA 510(k) clearance on 2023-03-01. It is manufactured by Advantis Medical Imaging Single Member P.C.. The 510(k) number is K222975.

When was Advantis Platform approved by the FDA?

Advantis Platform received FDA 510(k) clearance on 2023-03-01, under approval number K222975.

What company makes Advantis Platform?

Advantis Platform is manufactured by Advantis Medical Imaging Single Member P.C..

What is the FDA product code for Advantis Platform?

The FDA product code for Advantis Platform is LLZ.

Other Devices by Advantis Medical Imaging Single Member P.C.

K202808Brainance MD

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑